Andrew Taussig in Maitland, Florida

Additional Medical Specialties Include:
CARDIOVASCULAR DISEASE (CARDIOLOGY), INTERNAL MEDICINE

Medical School: Emory University School Of Medicine
Graduation Year: 1978
The Primary Medical Specialty for Andrew Taussig is listed as: Interventional Cardiology
Approximate Years of Experience: 46
PAC (PECOS ID)#: 2668413923
NPI #: 1154315778
NPI Created On: 09/09/2005
NPI Last Updated Listed as: 10/05/2020
Primary Taxonomy Code: 207RC0000X
License Number:
ME44365
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Celtic Insurance Company
• Humana
• Blue Cross Blue Shield
• Oscar Insurance Company of Florida
• Medicare

They are listed as accepting new patients in some locations.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

1. Replacement of aortic valve with prosthetic valve, accessed through the skin
2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
3. Routine ekg using at least 12 leads including interpretation and report
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
5. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
6. Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart
7. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
8. New patient office or other outpatient visit, typically 30 minutes
9. New patient office or other outpatient visit, typically 45 minutes
10. Established patient office or other outpatient visit, typically 10 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Physician telephone patient service, 5-10 minutes of medical discussion
14. Physician telephone patient service, 11-20 minutes of medical discussion
15. Technetium tc-99m sestamibi, diagnostic, per study dose
16. Injection, regadenoson, 0.1 mg